Clinical-Stage Platforms
Part of Biotech - Drug Development
 TMO | Thermo Fisher Scientific, Inc. | $212.2b | $629.03 | -0.7% | 542 |
 A | Agilent Technologies Inc. | $39.1b | $155.99 | +1.3% | 722 |
 IQV | IQVIA Holdings Inc. | $38.7b | $259.14 | 0.0% | 4 |
 WAT | Waters Corp | $36.8b | $417.26 | +1.3% | 2.3K |
 RPRX | Royalty Pharma plc Class A Ordinary Shares | $25.3b | $61.75 | 0.0% | 21 |
 WST | West Pharmaceutical Services, Inc. | $24.5b | $348.46 | 0.0% | 30 |
 MEDP | Medpace Holdings, Inc. Common Stock | $16.0b | $635.54 | 0.0% | N/A |
 ASND | Ascendis Pharma A/S Ordinary Share | $16.0b | $250.19 | 0.0% | N/A |
 RVTY | Revvity, Inc. | $12.9b | $126.44 | 0.0% | 11 |
 ICLR | Icon Plc | $12.6b | $169.50 | 0.0% | N/A |
 TECH | Bio-Techne Corp. | $11.2b | $72.17 | 0.0% | 75 |
 CRL | Charles River Laboratories International, Inc. | $11.2b | $299.75 | 0.0% | 2 |
 HALO | Halozyme Therapeutics, Inc. | $9.8b | $105.44 | 0.0% | 544 |
 BRKR | Bruker Corporation | $9.6b | $56.63 | 0.0% | N/A |
 AVTR | Avantor, Inc. | $9.3b | $14.50 | 0.0% | N/A |
 QGEN | QIAGEN N.V. | $8.7b | $43.35 | -1.2% | 1.2K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | $8.5b | $122.10 | 0.0% | 10 |
 RGEN | Repligen Corp | $8.3b | $178.04 | 0.0% | 3 |
 TWST | Twist Bioscience Corporation Common Stock | $6.3b | $148.02 | 0.0% | 2.5K |
 CGON | CG Oncology, Inc. Common stock | $6.3b | $78.05 | 0.0% | 1.0K |
 LGND | Ligand Pharmaceuticals Inc. | $5.8b | $287.91 | 0.0% | N/A |
 MANE | Veradermics, Incorporated | $4.3b | $102.73 | 0.0% | 76 |
 CELC | Celcuity Inc. Common Stock | $4.2b | $95.64 | 0.0% | 9 |
 RLAY | Relay Therapeutics, Inc. Common Stock | $4.1b | $19.65 | 0.0% | 1.1K |
 OGN | Organon & Co. | $3.6b | $13.75 | 0.0% | 98 |
 KOD | Kodiak Sciences Inc Common Stock | $2.6b | $39.52 | 0.0% | 10 |
 TRVI | Trevi Therapeutics, Inc. Common Stock | $2.5b | $16.55 | 0.0% | 41 |
 NRIX | Nurix Therapeutics, Inc. Common stock | $2.4b | $26.70 | 0.0% | N/A |
 DAWN | Day One Biopharmaceuticals, Inc. Common Stock | $2.2b | $21.52 | -0.0% | 3.0M |
 SLS | SELLAS Life Sciences Group, Inc. Common Stock | $2.2b | $13.88 | 0.0% | 6.1K |
 TYRA | Tyra Biosciences, Inc. Common Stock | $1.9b | $26.50 | 0.0% | 20 |
 FTRE | Fortrea Holdings Inc. Common Stock | $1.8b | $18.54 | 0.0% | N/A |
 GENB | Generate Biomedicines, Inc. Common Stock | $1.8b | $16.96 | 0.0% | 14.9K |
 BCAX | Bicara Therapeutics Inc. Common Stock | $1.8b | $24.89 | 0.0% | 953 |
 ABCL | AbCellera Biologics Inc. Common Shares | $1.7b | $12.22 | 0.0% | 19.1K |
 RXRX | Recursion Pharmaceuticals, Inc. Class A Common Stock | $1.7b | $3.49 | 0.0% | 86.6K |
 ZYME | Zymeworks Inc. | $1.6b | $29.49 | 0.0% | 788 |
 HROW | Harrow, Inc. Common Stock | $1.4b | $39.34 | 0.0% | 50 |
 GLUE | Monte Rosa Therapeutics, Inc. Common Stock | $1.4b | $14.38 | 0.0% | N/A |
 ALVO | Alvotech Ordinary Shares | $1.4b | $4.84 | 0.0% | 445 |
 ABSI | Absci Corporation Common Stock | $1.3b | $9.50 | 0.0% | 2.2K |
 CERT | Certara, Inc. Common Stock | $1.3b | $8.22 | 0.0% | 33 |
 INBX | Inhibrx Biosciences, Inc. Common Stock | $1.2b | $125.44 | 0.0% | 68 |
 VOR | Vor Biopharma Inc. Common Stock | $1.2b | $23.63 | 0.0% | N/A |
 SDGR | Schrodinger, Inc. Common Stock | $1.1b | $19.43 | 0.0% | 1.5K |
 PCRX | Pacira BioSciences, Inc. Common Stock | $1.1b | $25.91 | 0.0% | N/A |
 OPK | Opko Health Inc. | $1.0b | $1.51 | 0.0% | 92 |
 MRVI | Maravai LifeSciences Holdings, Inc. Class A Common Stock | $0.9b | $8.97 | 0.0% | 814 |
 SANA | Sana Biotechnology, Inc. Common Stock | $0.9b | $4.11 | 0.0% | 298 |
 CADL | Candel Therapeutics, Inc. Common Stock | $0.7b | $13.55 | 0.0% | 192 |